logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2010 or most recent year available

Part (ii) All outpatient clients, ratio of males to females by country and primary drug

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsGender and drug known
Belgium4.44.22.41.4:6.05.62.96309
Bulgaria4.9:5.01.0:::1.3982
Czech Republic1.81.01.50.62.0:3.10.51958
Denmark3.15.82.71.91.5:4.03.94513
Germany3.35.52.90.73.31.66.23.160398
Estonia(1)3.4:3.4:::2.0:665
Ireland2.35.02.91.65.01.25.32.65353
Greece5.88.7:2.8:4.06.0:3374
Spain(2)5.36.04.11.63.38.96.32.252278
France3.43.72.81.93.53.56.93.134543
Italy(3)4.58.62.41.22.0:12.61.039836
Cyprus5.624.0:0.4::9.6:670
Latvia(4)3.9:3.11.06.010.28.45.41699
Lithuania:::::::::
Luxembourg2.80.7::::::104
Hungary3.55.13.81.0:8.09.93.53495
Malta(5)5.25.65.0::1.06.62.51907
Netherlands(6)4.86.13.51.12.22.53.90.911417
Austria2.64.62.52.24.0:5.61.33146
Poland(7)3.0:2.50.80.56.04.74.0795
Portugal(8)6.74.51.70.73.0:7.05.03157
Romania5.14.08.52.06.08.04.92.3741
Slovenia3.93.0:1.0::4.4:794
Slovakia3.15.03.70.8:5.012.8:721
Finland1.7:2.02.2::2.70.5738
Sweden2.218.01.81.63.00.05.13.22479
United Kingdom(9)2.83.51.91.72.01.43.41.8114524
Croatia5.05.25.31.0::7.53.36895
Turkey:::::::::
Norway(10)2.45.92.31.0:0.53.32.44796
Total3.45.32.41.32.42.45.32.23.9
Total base177746605671596474951297784989355499368287
 

Notes:

Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented.

(1) Data are from outpatient, inpatient treatment centres and prisons (aggregated data).

(2) Data are from 2009. Data are from Outpatient treatment centres and some treatment units in prison (aggregated data).

(3) In 2010 around 29% of all clients and 30% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(4) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(5) Data refers to outpatient and inpatient treatment centres, low-threshold services and prisons (aggregated data).

(6) Data are from outpatient, inpatient treatment centres and Low-threshold services (aggregated data).

(7) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(8) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Other substances includes patients with alcohol and tobacco.

(9) Data are from 1st of April 2009 to 31st March 2010.

(10) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — TDI — outpatient treatment centres.

Page last updated: Monday, 09 July 2012